Finance News Network: Starpharma gets binding agreement for VivaGel
11 January 2012
Rebecca Richardson of Finance News Network presents on Starpharma's written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA’s Special Protocol Assessment (SPA) scheme.
Go to the video (external link)
This document contains Forward Looking Statements